Who are ADC Therapeutics SA's main suppliers?

ADC Therapeutics SA (ADCT) key suppliers include: HEALTHCARE-ROYALTY-MANAGEMENT-LLC, GH Research PLC, Oaktree Specialty Lending Corporation, Pyxis Oncology, Inc.. View the full supplier network at chainsifter.com/chain/ADCT.

Who are ADC Therapeutics SA's major customers?

ADC Therapeutics SA (ADCT) key customers include: AMERISOURCEBERGEN-CORPORATION, Cardinal Health, Inc., Cardinal Health, Inc., McKesson Corporation, McKesson Corporation and 3 more. View the full customer network at chainsifter.com/chain/ADCT.

What sector is ADC Therapeutics SA in?

ADC Therapeutics SA (ADCT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ADC Therapeutics SA Supplier List (ADCT): 4 Verified Suppliers

4Suppliers

8Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

ADC Therapeutics SA (ADCT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships

2Distinct source URLs

10High confidence

0.820Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

ADC Therapeutics SA Suppliers

Ticker	Name	Confidence	Evidence
HEALTHCARE-ROYALTY-MANAGEMENT-LLC	HEALTHCARE-ROYALTY-MANAGEMENT-LLC	80%	The Company is relying on this exemption from registration based in part on representations made in the warrants.
GHRS	GH Research PLC	72%	Reciprocal relationship from GHRS graph: 1 million for the year ended December 31, 2024. This movement is primarily as a result of the translation of our assets and liabilities from their denominated…
OCSL	Oaktree Specialty Lending Corporation	72%	Reciprocal relationship from OCSL graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from OCSL graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from OCSL g…
PYXS	Pyxis Oncology, Inc.	72%	Reciprocal relationship from PYXS graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from PYXS graph: ter prove to have greater commercial potential. Our resource allocation deci…

ADC Therapeutics SA Customers

Ticker	Name	Confidence	Evidence
AMERISOURCEBERGEN-CORPORATION	AMERISOURCEBERGEN-CORPORATION	92%	Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 AmerisourceBergen …
CAH	Cardinal Health, Inc.	92%	Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 Cardinal Health 25…
CAH	Cardinal Health, Inc.	92%	Reciprocal relationship from CAH graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from CAH graph: Reciprocal relationship from ADCT graph: Customers from which we derive more t…
MCK	McKesson Corporation	92%	Reciprocal relationship from MCK graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from MCK graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from MCK grap…
MCK	McKesson Corporation	92%	Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 McKesson 36 % 34 %
PYXS	Pyxis Oncology, Inc.	72%	Reciprocal relationship from PYXS graph: ter prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitab…
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	by collaborations and royalty financings and sales of ZYNLONTA in the United States. For a description of the Loan Agreement, Amended HCR Agreement and other license and collaboration agreements, see…
OWL-ROCK-CAPITAL-ADVISORS-LLC	OWL-ROCK-CAPITAL-ADVISORS-LLC	62%	to the Loan Agreement with certain affiliates and/or funds managed by each of Oaktree Capital Management, L.P. and Owl Rock Capital Advisors LLC, as lenders, and Owl Rock Opportunistic Master Fund I,…

ADC Therapeutics SA Debt Obligations

Instrument	Description	Confidence	Evidence
ADCT-DEBT	Debt stack $6.2M	90%	Market cache reports total debt of $6.2M.
ADCT-DEBT-7506	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-31.
ADCT-DEBT-7505	Warrants outstanding: 27743685	90%	xbrl warrant detail from xbrl 2026-03-31.

ADC Therapeutics SA Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ADC Therapeutics SA.

ADC Therapeutics SA Ownership

Holder	Name	Confidence	Evidence
ADCT-OWNER-REDMILE-GROUP-LLC	Redmile Group, LLC	90%	13F overlay lists Redmile Group, LLC as top holder; 118 tracked holders.

ADC Therapeutics SA Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
GILD	Gilead Sciences, Inc.	100.00	2
GNMSF	Genmab A/S	100.00	2
ARDX	Ardelyx, Inc.	100.00	2
HLNCF	Haleon plc	100.00	2
HALO	Halozyme Therapeutics, Inc.	100.00	2
HLN	Haleon plc	100.00	2
ACAD	ACADIA Pharmaceuticals Inc.	100.00	2
CVS	CVS Health Corporation	100.00	2
EMMA	Emmaus Life Sciences, Inc.	100.00	2
ESTA	Establishment Labs Holdings Inc.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
BTAI	BioXcel Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
GRDN	Guardian Pharmacy Services, Inc.	100.00	2
CLDX	Celldex Therapeutics, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
CAH	Cardinal Health, Inc.	100.00	1	['customer']
CLH	Clean Harbors, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
FBIO	Fortress Biotech, Inc.	100.00	2

ADC Therapeutics SA Supply Chain